✓ verified = confirmed by human source
◇ research = AI-assisted, pending confirmation
Exit Type◇ research
Unknown
Subsequent Funding◇ research
$9,100,000
Received VC Funding◇ research
Yes
Current Employees◇ research
9
Peak Employees◇ research
—
Relocated◇ research
Yes — TX
SBIR/STTR Awards◇ research
None
Filed Form D◇ research
Yes
Used Crowdfunding◇ research
No
Notes
Company site describes headquarters in Houston and Lexington. SEC Form D filed in 2020; 2023 founder profile said the company had raised about $20M overall and closed about $6M of its Series A target. I used $6M as the conservative verified follow-on amount for this pass.
[Deep research 2026-04-11] Company relocated primary headquarters to Houston, TX (4800 Fournace Place, Bellaire) while maintaining Lexington, KY site. Additional $3.1M raised in 2023 per SEC filing, bringing total post-KAITC funding to ~$9.1M. No USPTO patents found despite NGS diagnostics focus. No SBIR/STTR grants identified. Partnership with Louisville Health Equity Innovation Hub announced Feb 2023.
Last updated: Apr 11, 2026 · Evidence score: 4/5